CAD and neoplasm: Western blot analysis of tumor homogenates from the orthotopic VCaP xenografts also showed a trend of increase in both GR and l-CaD expression in the tumors treated with the antiandrogen (apalutamide), although the expressions were heterogeneous as expected based on our IHC analyses (Fig. 5G).